Diamond JR, Becerra C, Richards D, Mita A, et al. Phase Ib clinical trial of the anti-frizzled antibody vantictumab (OMP-18R5) plus paclitaxel in patients with locally advanced or metastatic HER2-negative breast cancer. Breast Cancer Res Treat 2020 Aug 14. pii: 10.1007/s10549-020-05817.
PMID: 32803633